SCHEMBL17547855

SCHEMBL17547855

CC(C)c1c(-c2cccc(-c3ccn[nH]3)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 10/20 0.37
▸ CD74 P04233 1/20 0.36
▸ MIF P14174 1/20 0.36
▸ KDM5B Q9UGL1 2/20 0.36
▸ KDM6B O15054 1/20 0.36
▸ KDM5C P41229 1/20 0.36
▸ KDM5D Q9BY66 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ PHF8 Q9UPP1 1/20 0.36
▸ KDM4D Q6B0I6 1/20 0.35
▸ MET P08581 1/20 0.35
▸ CTSV O60911 1/20 0.35
▸ CTSL P07711 1/20 0.35
▸ CTSB P07858 1/20 0.35
▸ CTSS P25774 1/20 0.35
▸ NOTUM Q6P988 1/20 0.34
▸ CLK1 P49759 1/20 0.33
▸ CLK2 P49760 1/20 0.33
▸ CLK3 P49761 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092478 0.88 KDM5A (0.36) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092243 0.86 KDM5A (0.43) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092448 0.84 KDM5B (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092493 0.84 KDM5B (0.48) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092293 0.84 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092327 0.84 KDM5A (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17085740 0.83 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16050761 0.83 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092255 0.83 KDM5B (0.42) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092249 0.83 KDM5A (0.47) KDM5AKDM5BKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885CD74 4193/4885MIF 4331/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885CD74 4193/4885MIF 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback